Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
Clinical trial NCT06663098 · RECRUITING
Trial details
- NCT number
- NCT06663098
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-24
- Primary completion
- 2028-08-30
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.